1. ICH International Conference on Harmonisation, Stability Testing of new Drug Substances and Products Q1A (R2), (2003). https://database.ich.org/sites/default/files/Q1A%28R2%29 Guideline.pdf (accessed May 9, 2023).
2. Development of forced degradation and stability indicating studies of drugs—A review;Blessy;J. Pharm. Anal.,2014
3. FDA, Analytical Procedures and Methods Validation for Drugs and Biologics Guidance for Industry, (2015) 1–18. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmand/orhttp://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm (accessed May 9, 2023).
4. Univariate versus multivariate spectrophotometric methods for the simultaneous determination of omarigliptin and two of its degradation products, Spectrochim;Kelani;Acta Part A Mol. Biomol. Spectrosc.,2022
5. Design, optimization, and validation of chemometrics-assisted spectrophotometric methods for simultaneous determination of etodolac and thiocolchicoside in pharmaceuticals;Albayrak;J. Anal. Sci. Technol.,2019